A radical new route to chiral drug scaffolds
Researchers have developed a new catalytic method to directly and selectively modify a specific carbon-hydrogen bond in a class of nitrogen-containing compounds called N-alkyl anilines. Using a combination of light and metal catalysts, the technique enables the attachment of complex aromatic groups to these molecules with high precision and control over the three-dimensional shape (enantioselectivity) of the final product, a feat that was previously a major synthetic challenge.
Why it might matter to you:
This method provides a powerful, streamlined tool for constructing complex, three-dimensional nitrogen-containing molecules, which are central to many pharmaceuticals. For a medicinal chemist, it could significantly accelerate the exploration of novel chemical space around privileged aniline scaffolds, enabling the rapid synthesis of new chiral candidates for biological testing. The reported tolerance for various functional groups means it could be applied to late-stage diversification of advanced intermediates, a key strategy in modern drug discovery.
If you wish to receive daily, weekly, biweekly or monthly personalized briefings like this, please.
Stay curious. Stay informed — with
Science Briefing.
